153 related articles for article (PubMed ID: 19027281)
1. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
[TBL] [Abstract][Full Text] [Related]
2. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
3. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.
Daniels JM; de Graaff CS; Vlaspolder F; Snijders D; Jansen HM; Boersma WG
Clin Microbiol Infect; 2010 Jun; 16(6):583-8. PubMed ID: 19681947
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. [Exacerbations of chronic obstructive pulmonary disease and the role of sputum bacteriological examination].
Noweta K; Frankowska M; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2006; 74(4):396-402. PubMed ID: 17427149
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
7. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
9. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
10. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
11. Reply to: Brusse-Keizer MGJ, et al. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Stockley RA; Pye A
Respir Med; 2009 Jun; 103(6):939-40. PubMed ID: 19321328
[No Abstract] [Full Text] [Related]
12. Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.
Brusse-Keizer M; ten Bokum L; Movig K; van der Valk P; Kerstjens H; van der Palen J; Hendrix R
COPD; 2011 Apr; 8(2):66-70. PubMed ID: 21495834
[TBL] [Abstract][Full Text] [Related]
13. Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs.
Burley CJ; Masterton RG; Lovell DP
J Infect; 2007 Sep; 55(3):226-32. PubMed ID: 17640738
[TBL] [Abstract][Full Text] [Related]
14. [Decision guidance for antibiotic treatment of acute exacerbation of COPD].
Kolditz M; Höffken G
MMW Fortschr Med; 2007 Mar; 149(11):38-40; quiz 41. PubMed ID: 20104700
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
Burgel PR
Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
18. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
19. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.
Allegra L; Blasi F; Diano P; Cosentini R; Tarsia P; Confalonieri M; Dimakou K; Valenti V
Respir Med; 2005 Jun; 99(6):742-7. PubMed ID: 15878491
[TBL] [Abstract][Full Text] [Related]
20. Bacterial exacerbations of chronic obstructive pulmonary disease. The role of lung function in aetiology of exacerbation.
Kieszko R; Szmygin-Milanowska K; Chudnicka A; Gołebiowska I; Łagozna J; Milanowski J
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):475-80. PubMed ID: 15315034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
